Repurposed Alzheimer’s Drug Could Treat Glioblastoma
Summary: Research indicates that BACE1 inhibitors, a drug class developed for Alzheimer’s disease, may be repurposed to treat glioblastoma by reprogramming tumor-associated macrophages to attack tumor cells. Source: Cleveland Clinic New research from the Cleveland Clinic reveals that drugs initially developed to target Alzheimer’s disease could offer a promising new approach for glioblastoma, the most … Read more